BioSpace News Archive

Press Releases

Obsidian Therapeutics to Present Phase 2 Clinical Data for OBX-115 in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting

May 22, 2026
·
11 min read
Press Releases

City of Hope Researchers Present Advances in Targeted Therapies, Microbiome Science and Blood Cancers at ASCO 2026

May 22, 2026
·
9 min read
Press Releases

Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting

May 22, 2026
·
10 min read
Press Releases

858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting

May 22, 2026
·
3 min read
Press Releases

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

May 22, 2026
·
4 min read
Press Releases

Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting

May 22, 2026
·
2 min read
Press Releases

Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline

May 22, 2026
·
18 min read
Press Releases

New ASCO and EHA 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology

May 22, 2026
·
19 min read
Press Releases

Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types

May 22, 2026
·
17 min read
Press Releases

Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting

May 22, 2026
·
5 min read